Clinical Trial Update: Rebamipide Versus Diquafosol for Perioperative Dry Eye in Cataract Surgery [Phase 4]

View source ↗

Summary

Phase 4 trial comparing Rebamipide and Diquafosol for perioperative dry eye in cataract surgery, sponsored by Samsung Medical Center.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cataract
• Dry Eye Disease

Drugs mentioned

• Diquafosol (diquafosol tetrasodium)
• Rebamipide (rebamipide)

Snippet

Sponsor: Samsung Medical Center | Conditions: Dry Eye Disease (DED), Cataract | Phase 4 | Status: NOT_YET_RECRUITING